Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population
Cancer Cell · 2023-06 · 41 (6) · 1017-1031.e4
DOI: 10.1016/j.ccell.2023.04.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2023-06. Verfasst von Isabelle A van Zeventer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Neoplasms, Myeloproliferative Disorders. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: European Union, Rijksuniversiteit Groningen, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
Knowledge about evolution of clonal hematopoiesis, which may drive malignant progression, is crucial for clinical decision-making. We investigated the landscape of clonal evolution by error-corrected sequencing on 7,045 sequential samples from 3,359 individuals in the prospective population-based Lifelines cohort, with a special focus on cytosis and cytopenia. Spliceosome (SRSF2/U2AF1/SF3B1) and JAK2 mutated clones show highest growth rates over a median 3.6-year period, while clone sizes for DNMT3A and TP53 increase only marginally, independent of cytosis or cytopenia. Nevertheless, large differences are observed between individuals carrying the same mutation, indicative of modulation by non-mutation-related factors. Clonal expansion is not dependent on classical cancer risk factors (e.g., smoking). Risk for incident myeloid malignancy diagnosis is highest for JAK2, spliceosome, or TP53 mutations and absent for DNMT3A, and it is mostly preceded by cytosis or cytopenia. The results provide important insight into high-risk evolutionary patterns to guide monitoring of "CHIP" and "CCUS."
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
- Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands.
- Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
- Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands; Department of Public Health, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands; Department of H…
- Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: joop.jansen@radboudumc.nl.
- Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: g.huls@umcg.nl.
Förderung
- European Union
- Rijksuniversiteit Groningen
- Horizon 2020 Framework Programme
- Ministerie van Volksgezondheid, Welzijn en Sport
- Ministerie van Economische Zaken
- Horizon 2020
- Stanford Genome Technology Center
Zitieren
APA
van Zeventer, I. A., de Graaf, A. O., Salzbrunn, J. B., Nolte, I. M., Kamphuis, P., Dinmohamed, A., van der Reijden, B. A., Schuringa, J. J., Jansen, J. H., & Huls, G. (2023). Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population. Cancer Cell, 41(6), 1017-1031.e4. https://doi.org/10.1016/j.ccell.2023.04.006
Vancouver
van Zeventer IA, de Graaf AO, Salzbrunn JB, Nolte IM, Kamphuis P, Dinmohamed A, et al. Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population. Cancer Cell. 2023;41(6):1017-1031.e4. doi:10.1016/j.ccell.2023.04.006
BibTeX
@article{vanZeventer2023,
author = {van Zeventer, Isabelle A and de Graaf, Aniek O and Salzbrunn, Jonas B and Nolte, Ilja M and Kamphuis, Priscilla and Dinmohamed, Avinash and van der Reijden, Bert A and Schuringa, Jan Jacob and Jansen, Joop H and Huls, Gerwin},
title = {Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population},
journal = {Cancer Cell},
year = {2023},
volume = {41},
number = {6},
pages = {1017--1031.e4},
doi = {10.1016/j.ccell.2023.04.006}
}
EUVIMED